Market Cap
$183.26 M
+$6.90 M+3.91%
Wed, 27 Nov 2024 22:55:39 GMT
Summary:
Galectin Therapeutics market capitalization is currently $183.26 million, with a rise of +$6.90 million (+3.91%) during the most recent trading day. Over the past year, it has increased by +$60.19 million (+48.90%). GALT market cap is now -47.38% below its all-time high of $348.29 million.GALT Market Cap Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GALT Market Cap Performance
| PeriodPeriod | Market capMarket cap | PricePrice | Shares outstandingShares outstanding | TTM Dividend per shareTTM Dividend per share |
|---|---|---|---|---|
| todaytoday | +3.9% | +3.9% | +0.7% | - |
| 1 m1 month | +17.2% | +16.3% | - | - |
| 3 m3 months | +10.2% | +9.4% | - | - |
| 6 m6 months | -3.3% | -4.3% | - | - |
| ytdytd | +78.5% | +75.9% | - | - |
| 1 y1 year | +48.9% | +46.7% | +1.5% | - |
| 5 y5 years | -1.5% | -10.7% | +10.3% | - |
GALT Market Cap High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $193 M | -5.2% | $155 M | +18.1% |
| 3 m | 3 months | $193 M | -5.2% | $150 M | +22.1% |
| 6 m | 6 months | $193 M | -5.2% | $125 M | +46.4% |
| 1 y | 1 year | $262 M | -30.1% | $98 M | +86.4% |
| 3 y | 3 years | $262 M | -30.1% | $61 M | +199.4% |
| 5 y | 5 years | $292 M | -37.2% | $61 M | +199.4% |
| alltime | all time | $348 M | -47.4% | $2.88 M | +6270.3% |
Galectin Therapeutics Market Cap History
| Date | Value |
|---|---|
| 2024 | $183.26 M(+78.5%) |
| 2023 | $102.68 M(+52.9%) |
| 2022 | $67.15 M(-45.3%) |
| 2021 | $122.84 M(-3.9%) |
| 2020 | $127.85 M(-21.4%) |
| 2019 | $162.72 M(+15.2%) |
| 2018 | $141.28 M(+18.2%) |
| 2017 | $119.54 M(+270.6%) |
| 2016 | $32.25 M(-31.8%) |
| 2015 | $47.27 M(-38.8%) |
| 2014 | $77.30 M(-48.0%) |
| Date | Value |
|---|---|
| 2013 | $148.57 M(+351.2%) |
| 2012 | $32.92 M(-55.8%) |
| 2011 | $74.42 M(+29.4%) |
| 2010 | $57.52 M(+297.0%) |
| 2009 | $14.49 M(+235.7%) |
| 2008 | $4.32 M(-84.7%) |
| 2007 | $28.26 M(+93.1%) |
| 2006 | $14.63 M(-82.4%) |
| 2005 | $83.31 M(+22.0%) |
| 2004 | $68.29 M(-28.2%) |
| 2003 | $95.11 M(+72.3%) |
| 2002 | $55.20 M |
FAQ
- What is Galectin Therapeutics market capitalization?
- What is the all time high market cap for Galectin Therapeutics?
- What is GALT market capitalization year-to-date change?
- What is Galectin Therapeutics market cap year-on-year change?
What is Galectin Therapeutics market capitalization?
The current market cap of GALT is $183.26 M
What is the all time high market cap for Galectin Therapeutics?
Galectin Therapeutics all-time high market capitalization is $348.29 M
What is GALT market capitalization year-to-date change?
Galectin Therapeutics market capitalization has changed by +$80.59 M (+78.49%) since the beginning of the year
What is Galectin Therapeutics market cap year-on-year change?
Over the past year, GALT market capitalization has changed by +$60.19 M (+48.90%)